GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of why does nobody talk about non-peptide — 33 comments in the full submission. View in context.
759
c/orforglipron·submitted 4 months ago by u/rasmus_petrescu

why does nobody talk about non-peptide

Speculationbranch of 7 comments

Confession thread, sort of. I went from 0.5mg to 12.5mg much faster than I should have because the scale had stalled and I got impatient. The stall broke about 18 weeks later, at which point I had no way of knowing whether the dose increase did anything or whether it would have broken anyway. So now I have…

Read the full submission and all 33 comments →

This branch

7 comments, started 4 months ago
u/piotr_bruun101 points·4 months ago

Strongly agree. The supply impact would be huge.

replysharereportpermalink
u/dario_boateng64 points·4 months ago

What are you comparing it against though?

replysharereportpermalink
u/rasmus_petrescuOP36 points·4 months ago

the supply conversation changes if this approves

replysharereportpermalink
[removed]25 points·4 months ago

[removed by moderator]

replysharereportpermalink
u/rasmus_petrescuOP26 points·4 months ago

availability speculation must be flaired Speculation

replysharereportpermalink
u/purity_pedantanalytical62 points·4 months ago

no cold chain means ATTAIN, if approved

replysharereportpermalink
u/gustav_solberg22 points·4 months ago

the absorption problem is solved by non-peptide structure

replysharereportpermalink

← back to the whole thread

About c/orforglipron

The small-molecule oral: why a non-peptide agonist escapes the absorption problems of oral semaglutide, what the ATTAIN and ACHIEVE readouts showed, and what a pill with no refrigeration requirement would do to the entire supply conversation this site is built around.

21kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/orforglipron
c/orforglipron rules
  1. Small molecule, not a peptide. Purity discussion here is a different problem.
  2. Cite ATTAIN/ACHIEVE arms specifically when quoting numbers.
  3. Availability speculation must be flaired Speculation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/incretin_ivyu/phase_two_peteu/trialwatch_theo
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →